Wayne Bailey, MD
Rheumatology · Manassas, VANPI 1467698712
Payments from drug & device makers
Across 769 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Amgen$3K
- UCB, Inc.$2K
- Mallinckrodt Hospital Products Inc.$1K
- Novartis$1K
- ANI Pharmaceuticals, Inc.$1K
- plus $6K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 160 | $3,769 |
| Amgen(2 entities) | 131 | $2,839 |
| UCB, Inc. | 72 | $1,722 |
| Mallinckrodt Hospital Products Inc. | 41 | $1,429 |
| Novartis | 51 | $1,259 |
| ANI Pharmaceuticals, Inc. | 44 | $1,001 |
| AbbVie | 31 | $919 |
| Radius Health, Inc. | 49 | $814 |
| GSK | 31 | $734 |
| AstraZeneca(2 entities) | 22 | $480 |
| Pfizer | 24 | $461 |
| E.r. Squibb & Sons, L.L.C. | 20 | $441 |
| Lilly USA, LLC | 21 | $382 |
| Aurinia Pharma U.S., Inc. | 15 | $322 |
| Genentech USA, Inc. | 14 | $292 |
| Fresenius Kabi USA, LLC | 8 | $245 |
| Sandoz | 9 | $187 |
| Kyowa Kirin, Inc. | 4 | $98 |
| Fidia Pharma USA Inc. | 4 | $97 |
| Tersera Therapeutics LLC | 3 | $81 |
| Biocon Biologics Inc | 2 | $51 |
| Boehringer Ingelheim | 2 | $46 |
| Ultragenyx Pharmaceutical Inc. | 2 | $39 |
| Mylan Institutional Inc. | 1 | $30 |
| Si-bone, Inc. | 1 | $27 |
| Sanofi | 1 | $25 |
| Boston Scientific | 1 | $25 |
| Organon | 1 | $23 |
| Cumberland Pharmaceuticals, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Alvogen Inc | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $11 |
How this compares
$17,905 in reported general payments places this provider in the 85th percentile of 159 rheumatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Manassas
- Gineth Pinto-PatarroyoManassas$61K
- Mohsen GhafouriManassas$19K
- Parita VasaManassas$7K
- Peter LipskyCharlottesville$1.6M
- Sharukh ShroffDanville$1.5M
- Kristi MizelleNewport News$1.2M
- Phillip KempfArlington$467K
- Adegbenga BankoleRoanoke$355K
- Michael StrachanRichmond$158K
- Karim MasriRichmond$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.